Effect of ertugliflozin on left ventricular function in type 2 diabetes and pre-heart failure: the Ertu-GLS randomized clinical trial.

Cardiovasc Diabetol · 2024 · PMC11515769 · PMID 39438942

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline non-significantno p-value reported

Key echocardiographic parameters, such as LVGLS and LVEF, showed borderline non-significant differences between the groups (Table S2), while no significant differences were observed in the remaining parameters.

also in 434 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.